Skip to main content
  1. Right Decisions
  2. Maternity & Gynaecology Guidelines
  3. Gynaecology
  4. Gynaecology guidelines
  5. Back
  6. Guidelines A-Z (all Gynaecology guidelines)
  7. Management of suspicious cervix in pregnancy, Gynaecology (1091)
Important: please update your RDS app to version 4.7.3

Welcome to the March 2025 update from the RDS team

1.     RDS issues - resolutions

1.1 Stability issues - Tactuum implemented a fix on 24th March which we believe has finally addressed the stability issues experienced over recent weeks.  The issue seems to have been related to the new “Tool export” function making repeated calls for content when new toolkit nodes were opened in Umbraco. No outages have been reported since then, and no performance issues in the logs, so fingers crossed this is now resolved.

1.2 Toolkit URL redirects failing– these were restored manually for the antimicrobial calculators on the 13th March when the issue occurred, and by 15th March for the remainder. The root cause was traced to adding a new hostname for an app migrated from another health board and made live that day. This led to the content management system automatically creating internal duplicate redirects, reaching the maximum number of permitted redirects and most redirects therefore ceasing to function.

This issue should not happen again because:

  • All old apps are now fully migrated to RDS. The large number of migrations has contributed to the high number of automated redirects.
  • If there is any need to change hostnames in future, Tactuum will immediately check for duplicates.

1.3 Gentamicin calculators – Incidents have been reported incidents of people accessing the wrong gentamicin calculator for their health board.  This occurs when clinicians are searching for the gentamicin calculator via an online search engine - e.g. Google - rather than via the health board directed policy route. When accessed via an external search engine, the calculator results are not listed by health board, and the start page for the calculator does not make it clearly visible which health board calculator has been selected.

The Scottish Antimicrobial Prescribing Group has asked health boards to provide targeted communication and education to ensure that clinicians know how to access their health board antimicrobial calculators via the RDS, local Intranet or other local policy route. In terms of RDS amendments, it is not currently possible to change the internet search output, so the following changes are now in progress:

  • The health board name will now be displayed within the calculator and it will be made clear which boards are using the ‘Hartford’ (7mg/kg) higher dose calculator
  • Warning text will be added to the calculator to advise that more than one calculator is in use in NHS Scotland and that clinicians should ensure they access the correct one for their health board. A link to the Right Decision Service list of health board antimicrobial prescribing toolkits will be included with the warning text. Users can then access the correct calculator for their Board via the appropriate toolkit.

We would encourage all editors and users to use the Help and Support standard operating procedure and the Editors’ Teams channel to highlight issues, even if you think they may be temporary or already noted. This helps the RDS team to get a full picture of concerns and issues across the service.

 

2.     New RDS presentation – RDS supporting the patient journey

A new presentation illustrating how RDS supports all partners in the patient journey – multiple disciplines across secondary, primary, community and social care settings – as well as patients and carers through self-management and shared decision-making tools – is now available. You will find it in the Promotion and presentation resources for editors section of the Learning and support toolkit.

3.     User guides

A new user guide is now available in the Guidance and tips section of Resources for providers within the Learning and Support area, explaining how to embed content from Google Calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream and Jotforms into RDS pages. A webinar for editors on using this new functionality is scheduled for 1 May 3-4 pm (booking information below.)

A new checklist to support editors in making all the checks required before making a new toolkit live is now available at the foot of the “Request a new toolkit” standard operating procedure. Completing this checklist is not a mandatory part of the governance process, but we would encourage you to use it to make sure all the critical issues are covered at point of launch – including organisational tags, use of Alias URLs and editorial information.

4.Training sessions for RDS editors

Introductory webinars for RDS editors will take place on:

  • Tuesday 29th April 4-5 pm
  • Thursday 1st May 4-5 pm

Special webinar for RDS editors – 1 May 3-4 pm

This webinar will cover:

  1. a) Use of the new left hand navigation option for RDS toolkits.
  2. b) Integration into RDS pages of content from external sources, including Google Calendar, Google Maps and simple Jotforms calculators.

Running usage statistics reports using Google analytics

  • Wednesday 23rd April 2pm-3pm
  • Thursday 22nd May 2pm-3pm

To book a place on any of these webinars, please contact Olivia.graham@nhs.scot providing your name, role, organisation, title and date of the webinar you wish to attend.

5.New RDS toolkits

The following toolkits were launched during March 2025:

SIGN guideline - Prevention and remission of type 2 diabetes

Valproate – easy read version for people with learning disabilities (Scottish Government Medicines Division)

Obstetrics and gynaecology induction toolkit (NHS Lothian) – password-protected, in pilot stage.

Oral care for care home and care at home services (Public Health Scotland)

Postural care in care homes (NHS Lothian)

Quit Your Way Pregnancy Service (NHS GGC)

 

6.New RDS developments

Release of the redesign of RDS search and browse, archiving and version control functionality, and editing capability for shared content, is now provisionally scheduled for early June.

The Scottish Government Realistic Medicine Policy team is leading development of a national approach to implementation of Patient-Reported Outcome Measures (PROMs) as a key objective within the Value Based Health and Care Action Plan. The Right Decision Service has been commissioned to deliver an initial version of a platform for issuing PROMs questionnaires to patients, making the PROMs reports available from patient record systems, and providing an analytics dashboard to compare outcomes across services.  This work is now underway and we will keep you updated on progress.

The RDS team has supported Scottish Government Effective Prescribing and Therapeutics Division, in partnership with Northern Ireland and Republic of Ireland, in a successful bid for EU funding to test develop, implement and assess new integrated care pathways for polypharmacy, including pharmacogenomics. As part of this project, the RDS will be working with NHS Tayside to test extending the current polypharmacy RDS decision support in the Vision primary care electronic health record system to include pharmacogenomics decision support.

7. Implementation projects

We have just completed a series of three workshops consulting on proposed improvements to the Being a partner in my care: Realistic Medicine together app, following piloting on 10 sites in late 2024. This app has been commissioned by Scottish Government Realistic Medicine to support patients and citizens to become active partners in shared decision-making and encouraging personalised care based on outcomes that matter to the person. We are keen to gather more feedback on this app. Please forward any feedback to ann.wales3@nhs.scot

 

 

Management of suspicious cervix in pregnancy, Gynaecology (1091)

Warning

Objectives

To define the management of women who are pregnant and are found to have a concerning cervical appearance during speculum examination

Scope

To be applied to women who are pregnant and are found to have an abnormality of their cervix.

Audience

All healthcare professionals in Greater Glasgow and Clyde including midwives, doctors and nurses involved in the care of pregnant women where a cervical abnormality has been identified.

Please report any inaccuracies or issues with this guideline using our online form

Within pregnancy, speculum examinations are generally performed after a patient present with symptoms such as abnormal vaginal discharge, vaginal bleeding, pre-term labour or rupture of membranes.

Before the examination consider the following which can be determined by history taking.

  • Is infection suspected?
  • Has the patient had any previous treatment to her cervix?
  • Is there a history of abnormal smears?
  • Has she been sexually active recently?
  • Does she have a cervical suture or vaginal pessary in place?
  • Is she using vaginal pessaries which may change her vaginal discharge e.g. vaginal progesterone?
  • Is there a history consistent with early labour including rupture of membranes?

If cervical screening history is uncertain and the patient is ≥25 years of age, the national Scottish Cervical Call Recall System database (SCCRS) may contain relevant information.

Opportunistic cervical smears should not be taken during pregnancy within the Obstetric Department.

If concerns regarding cervical appearance, it is important to describe and document the size, number, consistency and origin of any cervical lesions, along with any contact bleeding.

If any concern over appearance of cervix at examination, confirmation should be made by the on call Consultant or senior trainee (ST6/7) in the first instance.

If a vaginal infection is suspected, high vaginal swabs should be taken and consideration of STI screen.  These may include Chlamydia/Gonorrhoea nucleic acid amplification tests (NAAT) vulvovaginal swab or lesion swab for PCR medium e.g. for herpes.

Patients presenting with vaginal bleeding should be managed in line with current guidelines for Antepartum Haemorrhage or Vaginal bleeding in <24 weeks. (see relevant guidelines for gestation)

The appearance of the cervix can change in normal pregnancy. Features can include an increase in cervical size, a bluish appearance due to increase vascularity.  These physiological changes may appear suspicious to an inexperienced clinician (2).

Most cervical abnormalities are benign and patients can be reassured and managed conservatively.  Some changes are described below.

  • Cervical ectopy – most common benign abnormality and may be associated with increased physiological discharge, no further investigation required.
  • Nabothian Follicles/Cysts – normal finding in women of childbearing age
  • Cervicitis/inflammation of the cervix – this can be acute or chronic and are most likely associated with Sexually Transmitted Infections (HSV, chlamydia, gonnorrhoea, trichomonas). Screening with appropriate swabs should be undertaken.
  • Condyloma (genital warts) - may be present in remainder of genital tract including vagina and vulva.

Cervical Polyp –They can be found in up to 4% of women, and are commonly asymptomatic.  However, in pregnancy they may present with vaginal bleeding or antepartum haemorrhage. They can be ectocervical, endocervical or endometrial in origin.

Risk of malignancy is low estimated at <0.1% in the pre-menopausal woman (3).  If there is clinical concern that the polyp may be atypical and/or previous unresolved abnormal cervical cytology, then referral for review at colposcopy via USOC (Urgent Suspicion of Cancer) pathway should be submitted.  This should be an urgently dictated letter, which is sent to colposcopy via Scottish Care Information gateway (SCI-gateway) referral pathway by the transcribing secretary.

All patients with cervical polyps, irrespective of antenatal management should be reviewed in postnatally (obstetrics or general gynaecology) at 6-12 weeks. This should be highlighted via Alert tab in Badger, and referral made using a dictated letter, which is sent to colposcopy via SCI-gateway referral pathway by the transcribing secretary.

Suspicious cervical mass - cervical carcinoma is rare in pregnancy with estimated prevalence 1-10/10 000 pregnancies (2). 

If malignancy is suspected on clinical examination in a stable patient, then referral for review at colposcopy via USOC (Urgent Suspicion of Cancer) pathway should be submitted.  This should be an urgently dictated letter, which is sent to colposcopy via SCI-gateway referral pathway by the transcribing secretary.

Referral to colposcopy should be made by senior trainee (ST6/7)/consultant by written referral including summary of pregnancy.  This should be an urgently dictated letter, which is sent to colposcopy via SCI-gateway referral pathway by the transcribing secretary.  It is useful to copy in the patient’s named Obstetrician and their own GP.

Referral should contain:

  • Patient’s named Obstetrician and contact details (may be useful to include their secretary as a contact point)
  • Presenting symptoms
  • Clinical findings indicating referral
  • Investigations undertaken e.g. swabs
  • Placental site
  • Any issues with pregnancy

Clinical assessment of the cervix will be undertaken and outcome of this examination will be shared with patient’s named consultant Obstetrician and referring clinician.

Unless the suspicion of malignancy is high at colposcopy, it is most likely that a conservative approach will be adopted.  Any further follow-up will be arranged by the colposcopist postnatally.

If a biopsy during pregnancy if felt to be warranted, this will generally be undertaken by an experienced colposcopist in a theatre setting after planning with the obstetric team. This is due to the associated increase in haemorrhage and complications.

Editorial Information

Last reviewed: 14/06/2023

Next review date: 31/05/2028

Author(s): Dr Victoria Flannigan, Consultant O&G, Dr Sandra Wong, Consultant O&G.

Approved By: Gynaecology Clinical Governance Group

Document Id: 1091

References
  1. Panayotidis, Costas & Cilly, Latika. (2013). Cervical Polypectomy during Pregnancy: The Gynaecological Perspective. J Genit Syst Disor. 2. 10.4172/2325-9728.1000108.
  2. China S, Sinha Y, Sinha D, Hillaby K. Management of gynaecological cancer in pregnancy.The Obstetrician & Gynaecologist2017;19:139–46. DOI: 10.1111/tog.1236
  3. Nelson AL, Papa RR, Ritchie JJ. Asymptomatic Cervical Polyps: Can We Just Let them Be? Women’s Health. March 2015:121-126. doi:10.2217/WHE.14.86